ArticleCell reports. Medicine2024

The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy.

Hongtu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.